Wellbiotec Co. Ltd. (010600) - Total Assets
Based on the latest financial reports, Wellbiotec Co. Ltd. (010600) holds total assets worth ₩31.95 Billion KRW (≈ $21.65 Million USD) as of December 2024. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Wellbiotec Co. Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.
Wellbiotec Co. Ltd. - Total Assets Trend (2002–2024)
This chart illustrates how Wellbiotec Co. Ltd.'s total assets have evolved over time, based on quarterly financial data. See shareholders equity of Wellbiotec Co. Ltd. for net asset value and shareholders' equity analysis.
Wellbiotec Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
Wellbiotec Co. Ltd.'s total assets of ₩31.95 Billion consist of 75.0% current assets and 25.0% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 22.9% |
| Accounts Receivable | ₩9.76 Billion | 30.6% |
| Inventory | ₩0.00 | 0.0% |
| Property, Plant & Equipment | ₩0.00 | 0.0% |
| Intangible Assets | ₩224.53 Million | 0.7% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2002–2024)
This chart illustrates how Wellbiotec Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Wellbiotec Co. Ltd. (010600) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Wellbiotec Co. Ltd.'s current assets represent 75.0% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 22.9% of total assets in 2024, up from 1.6% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 30.6% of total assets.
Wellbiotec Co. Ltd. Competitors by Total Assets
Key competitors of Wellbiotec Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Zhejiang Taihua New Material
SHG:603055
|
China | CN¥11.56 Billion |
|
Shanghai Shuixing Home Textile Co Ltd Class A
SHG:603365
|
China | CN¥3.96 Billion |
|
Hangzhou Wensli Silk Culture Co. Ltd.
SHE:301066
|
China | CN¥1.08 Billion |
|
Hunan Mendale Hometextile Co Ltd
SHE:002397
|
China | CN¥2.33 Billion |
|
Huafang Co Ltd
SHG:600448
|
China | CN¥3.46 Billion |
|
Kingdom Holdings Limited
F:K7A
|
Germany | €3.11 Billion |
|
Novita S.A.
WAR:NVT
|
Poland | zł186.04 Million |
|
Yoong Onn Corporation Bhd
KLSE:5159
|
Malaysia | RM407.94 Million |
Wellbiotec Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.23 | 1.88 | 1.59 |
| Quick Ratio | 2.23 | 1.80 | 1.04 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₩13.24 Billion | ₩18.18 Billion | ₩22.85 Billion |
Wellbiotec Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between Wellbiotec Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.30 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -47.0% |
| Total Assets | ₩31.95 Billion |
| Market Capitalization | $33.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values Wellbiotec Co. Ltd.'s assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Wellbiotec Co. Ltd.'s assets decreased by 47.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Wellbiotec Co. Ltd. (2002–2024)
The table below shows the annual total assets of Wellbiotec Co. Ltd. from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩31.95 Billion ≈ $21.65 Million |
-46.97% |
| 2023-12-31 | ₩60.24 Billion ≈ $40.82 Million |
+0.05% |
| 2022-12-31 | ₩60.21 Billion ≈ $40.80 Million |
-56.00% |
| 2021-12-31 | ₩136.83 Billion ≈ $92.73 Million |
+92.93% |
| 2020-12-31 | ₩70.92 Billion ≈ $48.06 Million |
-40.81% |
| 2019-12-31 | ₩119.82 Billion ≈ $81.20 Million |
+7.80% |
| 2018-12-31 | ₩111.16 Billion ≈ $75.33 Million |
+27.76% |
| 2017-12-31 | ₩87.01 Billion ≈ $58.96 Million |
+45.34% |
| 2016-12-31 | ₩59.86 Billion ≈ $40.57 Million |
+1.31% |
| 2015-12-31 | ₩59.09 Billion ≈ $40.04 Million |
-3.53% |
| 2014-12-31 | ₩61.25 Billion ≈ $41.51 Million |
+0.04% |
| 2013-12-31 | ₩61.23 Billion ≈ $41.49 Million |
-0.95% |
| 2012-12-31 | ₩61.81 Billion ≈ $41.89 Million |
-13.13% |
| 2011-12-31 | ₩71.15 Billion ≈ $48.22 Million |
+18.13% |
| 2010-12-31 | ₩60.24 Billion ≈ $40.82 Million |
-0.13% |
| 2009-12-31 | ₩60.32 Billion ≈ $40.87 Million |
-39.57% |
| 2008-12-31 | ₩99.81 Billion ≈ $67.64 Million |
-5.48% |
| 2007-12-31 | ₩105.59 Billion ≈ $71.56 Million |
-27.62% |
| 2006-12-31 | ₩145.88 Billion ≈ $98.86 Million |
-3.49% |
| 2005-12-31 | ₩151.15 Billion ≈ $102.43 Million |
+17.02% |
| 2004-12-31 | ₩129.16 Billion ≈ $87.53 Million |
+6.93% |
| 2003-12-31 | ₩120.79 Billion ≈ $81.86 Million |
+20.94% |
| 2002-12-31 | ₩99.88 Billion ≈ $67.69 Million |
-- |
About Wellbiotec Co. Ltd.
Wellbiotec Co., Ltd. produces and sells leather products in South Korea and internationally. The company provides leather products for shoes, hand bags, car seats, and handle covers. It also offers development, production, and sell of medicines and health functional foods; logistics consulting, transportation agency services, customs clearance, insurance, and storage services; and general and spe… Read more